{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:53:36Z","timestamp":1759366416680,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.revmed.2007.04.010","type":"journal-article","created":{"date-parts":[[2007,5,26]],"date-time":"2007-05-26T07:11:02Z","timestamp":1180163462000},"page":"689-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Int\u00e9r\u00eat du\u00a0dosage des\u00a0cha\u00eenes l\u00e9g\u00e8res libres d'immunoglobulines s\u00e9riques pour\u00a0le\u00a0diagnostic et\u00a0le\u00a0suivi des\u00a0gammapathies monoclonales"],"prefix":"10.1016","volume":"28","author":[{"given":"L.","family":"Guenet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Decaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Lechartier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ropert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Grosbois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2007.04.010_bib1","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1093\/clinchem\/40.11.2154","article-title":"The monoclonal gammopathies","volume":"40","author":"Kyle","year":"1994","journal-title":"Clin. Chem."},{"issue":"Pt 5","key":"10.1016\/j.revmed.2007.04.010_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/000456329503200510","article-title":"Quantification of serum proteins using capillary electrophoresis","volume":"32","author":"Jenkins","year":"1995","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.revmed.2007.04.010_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.revmed.2007.04.010_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3109\/00365517509095760","article-title":"Free light chains of immunoglobulins in normal serum and urine determined by radioimmunoassay","volume":"35","author":"Solling","year":"1975","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.revmed.2007.04.010_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains","volume":"48","author":"Katzmann","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.revmed.2007.04.010_bib6","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/clinchem\/48.9.1600","article-title":"Detection of monoclonal proteins in sera by capillary zone electrophoresis and free light chain measurements","volume":"48","author":"Marien","year":"2002","journal-title":"Clin. Chem."},{"year":"2006","series-title":"Serum Free Light Chain Analysis. 4th Edition","author":"Bradwell","key":"10.1016\/j.revmed.2007.04.010_bib7"},{"key":"10.1016\/j.revmed.2007.04.010_bib8","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2007.04.010_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.revmed.2007.04.010_bib10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(03)12457-9","article-title":"Serum test for assessment of patients with Bence Jones myeloma","volume":"361","author":"Bradwell","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2007.04.010_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/clinchem\/48.4.655","article-title":"Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma","volume":"48","author":"Abraham","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.revmed.2007.04.010_bib12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2007.04.010_bib13","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0889-8588(05)70125-8","article-title":"Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia","volume":"13","author":"Blade","year":"1999","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.revmed.2007.04.010_bib14","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","author":"Drayson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2007.04.010_bib15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1373\/clinchem.2004.046870","article-title":"Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice","volume":"51","author":"Katzmann","year":"2005","journal-title":"Clin. Chem."},{"key":"10.1016\/j.revmed.2007.04.010_bib16","doi-asserted-by":"crossref","first-page":"A3490","DOI":"10.1182\/blood.V106.11.3490.3490","article-title":"Serum Free-Lite Chain (sFLC) Assay in Multiple Myeloma (MM): Clinical Correlates and Prognostic Implications in Newly Diagnosed MM Patients Treated with Total Therapy 2 or 3 (TT2\/3)","volume":"106","author":"Cavallo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2007.04.010_bib17","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05045.x","article-title":"Serum free light chains for monitoring multiple myeloma","volume":"126","author":"Mead","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib18","doi-asserted-by":"crossref","first-page":"A4907","DOI":"10.1182\/blood.V104.11.4907.4907","article-title":"Measurement in Multiple Myeloma Patients Correlate with Known Monoclonal Paraprotein, Disease Stage and Therapy Response","volume":"104","author":"Engelhardt","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2007.04.010_bib19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2141.2005.05848.x","article-title":"Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma","volume":"132","author":"Hassoun","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.2004.05338.x","article-title":"Serum free light chains for monitoring multiple myeloma","volume":"128","author":"Tate","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0609.2000.90221.x","article-title":"Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group","volume":"65","author":"Knudsen","year":"2000","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib22","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/archinte.158.17.1889","article-title":"Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution","volume":"158","author":"Blade","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.revmed.2007.04.010_bib23","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1158\/1078-0432.CCR-05-0486","article-title":"Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma","volume":"11","author":"Nowrousian","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.revmed.2007.04.010_bib24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/0003-4819-143-11-200512060-00005","article-title":"Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial","volume":"143","author":"Clark","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2007.04.010_bib25","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1681\/ASN.2005010070","article-title":"Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?","volume":"16","author":"Ward","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.revmed.2007.04.010_bib26","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1681\/ASN.2006080821","article-title":"Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies","volume":"18","author":"Hutchison","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.revmed.2007.04.010_bib27","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5858\/1999-123-0126-PFTEOM","article-title":"Procedures for the evaluation of monoclonal immunoglobulins","volume":"123","author":"Keren","year":"1999","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.revmed.2007.04.010_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V77.2.257.257","article-title":"Response rates and survival in primary systemic amyloidosis","volume":"77","author":"Gertz","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2007.04.010_bib30","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood.V91.10.3662","article-title":"Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients","volume":"91","author":"Comenzo","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2007.04.010_bib31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2141.2003.04433.x","article-title":"Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy","volume":"122","author":"Lachmann","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib32","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1309\/LYWM47K2L8XYFFB3","article-title":"Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis","volume":"119","author":"Abraham","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.revmed.2007.04.010_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/sj.bmt.1705106","article-title":"Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis","volume":"36","author":"Sanchorawala","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.revmed.2007.04.010_bib34","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1182\/blood-2005-07-2922","article-title":"Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"107","author":"Dispenzieri","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2007.04.010_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2141.2004.04970.x","article-title":"Guidelines on the diagnosis and management of AL amyloidosis","volume":"125","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-065X.2003.00056.x","article-title":"Monoclonal gammopathies of undetermined significance: a review","volume":"194","author":"Kyle","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.revmed.2007.04.010_bib37","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1046\/j.1365-2141.1997.4943298.x","article-title":"A population-based registry on paraproteinaemia in The Netherlands. Comprehensive Cancer Centre West, Leiden, The Netherlands","volume":"99","author":"Ong","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib38","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance. Natural history in 241 cases","volume":"64","author":"Kyle","year":"1978","journal-title":"Am. J. Med."},{"key":"10.1016\/j.revmed.2007.04.010_bib39","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/jama.1984.03340380031018","article-title":"'Benign' monoclonal gammopathy. A misnomer?","volume":"251","author":"Kyle","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2007.04.010_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2007.04.010_bib41","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2007.04.010_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance","volume":"81","author":"Blade","year":"1992","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib43","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0755-4982(06)74771-6","article-title":"Suivi \u00e9volutif des gammapathies monoclonales de signification ind\u00e9termin\u00e9e. Etude r\u00e9trospective de 190 patients","volume":"35","author":"Decaux","year":"2006","journal-title":"Presse Med."},{"key":"10.1016\/j.revmed.2007.04.010_bib44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2141.2004.05169.x","article-title":"Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance","volume":"127","author":"Rajkumar","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2007.04.010_bib45","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2007.04.010_bib46","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4065\/81.12.1575","article-title":"Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays","volume":"81","author":"Katzmann","year":"2006","journal-title":"Mayo Clin. Proc."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307005516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866307005516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:21:36Z","timestamp":1759335696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866307005516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0248866307005516"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2007.04.010","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Int\u00e9r\u00eat du\u00a0dosage des\u00a0cha\u00eenes l\u00e9g\u00e8res libres d'immunoglobulines s\u00e9riques pour\u00a0le\u00a0diagnostic et\u00a0le\u00a0suivi des\u00a0gammapathies monoclonales","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2007.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}